These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8822340

  • 1. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S, Takahashi HE.
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y, Won YY, Baek MH, Lim SK.
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [Abstract] [Full Text] [Related]

  • 5. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
    Liu CC, Kalu DN.
    J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
    Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y.
    Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
    [Abstract] [Full Text] [Related]

  • 14. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Motoie H, Nakamura T, O'uchi N, Nishikawa H, Kanoh H, Abe T, Kawashima H.
    J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
    [Abstract] [Full Text] [Related]

  • 15. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V, Birchman R, Liang XG, Wu DD, Dempster DW, Lindsay R.
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [Abstract] [Full Text] [Related]

  • 16. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE, Thompson JM, Strewler GJ, Kinney JH.
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.